Stock ENVB ENVERIC BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Enveric Biosciences, Inc.

Equities

ENVB

US29405E2081

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
0.882 USD -3.18% Intraday chart for Enveric Biosciences, Inc. -4.98% -32.15%
Mar. 26 Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 19 Sector Update: Health Care Stocks Rise Late Afternoon MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Enveric Biosciences : Shareholder Meeting - Form 8-K
PU
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023
BU
Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sector Update: Health Care Stocks Rise Late Afternoon
MT
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading
MT
Enveric Biosciences Signs Licensing Term Sheets for Joint Disease Treatment Compounds; Shares Rise
MT
Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected
MT
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
BU
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
CI
Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets
BU
Enveric Biosciences Issues 228,690 Shares in Direct Offering
MT
Top Midday Gainers
MT
Wall Street Set to Open Higher Thursday as Inflation Data Meets Forecasts
MT
Investors Await Slate of Economic Data as US Futures Move Lower in Thursday's Premarket Session
MT
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
BU
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB
AQ
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
AQ
Sector Update: Health Care Stocks Rise in Late Afternoon
MT
Sector Update: Health Care Stocks Advance Friday Afternoon
MT
Enveric Biosciences Surging on Plans to Sell Cannabinoid IP Portfolio, Focus Shift to Psilocin Therapies
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENVB Stock
  4. News Enveric Biosciences, Inc.